Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a small segment of the general Australian pharmaceutical sector. The industry develops and manufactures animal health products, including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food-producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). The industry accounts for just over 5% of the pharmaceutical sector.
Over the five years through 2015-16, the industry has had a highly volatile performance due to various external shocks... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
Over the past five years, the industry has witnessed some positive growth in revenue as drought conditions eased and demand for companion animal and livestock health products increased. Industry value added (IVA), a measurement of an industry’s contribution to the overall economy, is expected to grow by an annualised 5.2% over the 10 years through 2020-21. While this is above forecast annualised GDP growth of 2.6% over the same period suggesting that the industry is outperforming the wider economy, this growth rate is distorted by the significant drop in IVA that occurred in the base year. Ignoring this anomaly, growth in IVA tends to lag that of the wider economy suggesting a mature industry... purchase to read more